Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Cancer Research|April 17, 2019
When Failure Is Worse Than Giving Up: The Case of CTLMario Paolo Colombo, Daniele LecisJournal of Experimental & Clinical Cancer Research : CR|December 2, 2021
Deciphering the nonsense-mediated mRNA decay pathway to identify cancer cell vulnerabilities for effective cancer therapyRoberta Bongiorno, Mario Paolo Colombo, Daniele LecisComputational and Structural Biotechnology Journal|February 16, 2019
Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer TreatmentFederica Cossu, Mario Milani, Eloise Mastrangelo, et al.Cancer Research|January 20, 2022
Few, but Efficient: The Role of Mast Cells in Breast Cancer and Other Solid TumorsMaria Teresa Majorini, Mario Paolo Colombo, Daniele LecisCancers|May 8, 2019
Immune Checkpoint Ligand Reverse Signaling: Looking Back to Go Forward in Cancer TherapyDaniele Lecis, Sabina Sangaletti, Mario P Colombo, et al.Current Biology : CB|April 21, 2009
The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damageGiacomo Buscemi, Laura Zannini, Enrico Fontanella, et al.The Journal of Biological Chemistry|August 12, 2003
Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear importLaura Zannini, Daniele Lecis, Sofia Lisanti, et al.Bioorganic & Medicinal Chemistry Letters|April 17, 2014
SPION-Smac mimetic nano-conjugates: putative pro-apoptotic agents in oncologyPierfausto Seneci, Mattia Rizzi, Luigi Ballabio, et al.Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agentsAldo Bianchi, Marcello Ugazzi, Luca Ferrante, et al.The FEBS Journal|July 29, 2018
Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPsAlessandro Corti, Mario Milani, Daniele Lecis, et al.Pageof 6